HeartLung.AI introduced its latest artificial intelligence-powered technologies, AI-CVD and AI-CAC, at the Society of Cardiovascular Computed Tomography (SCCT) 2025 conference. These tools are designed to transform the current capabilities of cardiac computed tomography (CT) by moving past the established boundaries of traditional calcium scoring methods.
The showcased AI-CAC solution aims to deliver deeper clinical insights by leveraging artificial intelligence to analyze cardiac CT scans beyond simply measuring coronary artery calcium. HeartLung.AI´s approach seeks to enhance risk stratification and diagnostic accuracy, making it possible for clinicians to detect cardiovascular disease earlier and manage patient care more effectively.
By integrating artificial intelligence into cardiac CT analysis, HeartLung.AI aspires to set new standards in non-invasive imaging for cardiovascular disease. The company’s innovations promise to empower healthcare providers with richer data, ultimately pushing the field closer toward predictive and personalized care for patients at risk of cardiovascular conditions.
